NCT04106609

Brief Summary

To test the effect of an individualized exercise oncology program on healthcare utilization, 30-day hospital readmission, pain, and cancer treatment tolerance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
251

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 23, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 25, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 27, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2021

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

June 7, 2024

Completed
Last Updated

June 7, 2024

Status Verified

June 1, 2024

Enrollment Period

2.2 years

First QC Date

September 25, 2019

Results QC Date

April 5, 2022

Last Update Submit

June 5, 2024

Conditions

Outcome Measures

Primary Outcomes (12)

  • Missed Fractions

    Total number of missed fractions, determined by electronic medical record

    12 weeks

  • Numbers of Breaks in Cancer Treatment

    Defined as missing 3 or more fractions due to patient condition, determined by electronic medical record

    12 weeks

  • Cost of Emergency Room Visits

    Medical expenditure and utilization, for each time a patient utilized an emergency room visit for the purpose of managing health problems in addition to the planned cancer care, determined by electronic medical record.

    12 weeks

  • Encounters

    Number of inpatient and outpatient hospital encounters, determined by electronic medical record

    12 weeks

  • Cost of Total Unplanned Expenditures

    Number of hospital readmissions for the same presenting issue, determined by electronic medical record

    12 weeks

  • Cost of Hospital Inpatient Care

    Hospital length of stay, in days, if applicable. Determined by electronic medical record.

    12 weeks

  • Cancer Treatment Adherence

    Percentage of patient adherence to their cancer treatment, determined by electronic medical record

    12 weeks

  • Cancer Treatment Symptom Management Medications

    Number of the different types of medications taken by patients for symptom management during their cancer treatment. Determined by electronic medical record.

    12 weeks

  • Cancer Treatment Related Side Effects

    Total number of cancer treatment related side effects

    12 weeks

  • Patient Rated Pain Score

    The Short Form-36 survey was used to measure pain. A high score defines a more favorable health state. Each item is scored on a 0 to 100 range, with the lowest and highest possible scores being 0 and 100, respectively.

    12 weeks, measured at the start of their exercise program during their initial assessment and at the 12-week follow-up re-assessment.

  • Cancer TreatmentTtolerance

    Measured by the Eastern Cooperative Oncology Group (ECOG) performance status score. Scale is from 0 to 5, with 0 being high functioning and no restriction and 5 being dead.

    12 weeks - ECOG performance status measurements were recorded at baseline and at the 12-week follow up appointment.

  • Quality of Life Measure: Utilizing McGill Quality of Life Survey and FACT-B Questionnaire

    McGill Quality of Life Survey: Physical Wellbeing (questions 1-4) - minimum score is 0, maximum score is 40. A higher score would be good and lower score would be bad. Social Wellbeing (questions 12, 14-16) - minimum score is 0, maximum score is 40. A higher score would be good and lower score would be bad. Emotional Wellbeing(questions 5-7, 13) - minimum score is 0 and maximum score is 40. A higher score would be bad and a lower score would be good Functional wellbeing (questions 8-11) - minimum score is 0, maximum score is 40. A higher score would be good and lower score would be bad. FACT-BREAST Survey: Minimum score is 0 and maximum is 148; 0 is not at all and 4 is very much, "good" or "bad" varies depending on the question; overall a higher score is good and a lower score is bad

    Baseline was at the time of enrollment and follow up was after 12-weeks.

Secondary Outcomes (2)

  • Adherence Rate

    12 weeks

  • Percentage of Participants Who Completed the Study (Attrition Rate)

    12 weeks

Study Arms (2)

Exercise Group

EXPERIMENTAL

Patients will complete a 60-minute exercise session once per week for 12 weeks. The exercise sessions will be individualized to the patient's needs and fitness level by a trainer. A patient will work with the same trainer throughout the study, who will plan the patient's individualized exercise regimen, and who will provide one-on-one supervision for the duration of each 60-minute session. Each 60-minute session will include cardiovascular, strength, and flexibility training. The intensity level for the aerobic exercise ranges from 30-45% of the individual's predicted VO2max, controlled by heart monitors and lasting 30 min. Strength training will involve a full body workout, with emphasis on all major muscle groups and employing machines, free weights, and resistance tubing. Patients will complete 3 sets of 10 repetitions for each strength exercise. Flexibility training will involve static stretching of all major muscle groups for 15-20 seconds at the completion of each workout.

Other: Supervised, individualized exercise oncology program

Control Group

ACTIVE COMPARATOR

The control group will receive the current standard of care, which includes a resource guide with various options available to the cancer survivor. Within this guide are tips for healthy eating and pictures of standard exercises to improve fitness.

Other: Current standard of care

Interventions

The study intervention is a supervised, individualized exercise oncology program described in previous literature2,3,12 and provided by Maple Tree Cancer Alliance, a non-profit organization providing exercise training to individuals with cancer (https://www.mapletreecanceralliance.org/). This organization was founded in 2011 and currently operates in 9 hospitals serving Ohio and Pennsylvania, offering free exercise programs and nutritional guidance to approximately 500 patients annually to help relieve side effects related to cancer treatment.

Exercise Group

Resource guide with various options available to cancer survivor. Within this guide are tips for healthy eating and pictures of standard exercises to improve fitness.

Control Group

Eligibility Criteria

Age30 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female; determined from electronic medical record
  • Initial stage 0, 1 or 2 breast cancer diagnosis within the past 12 weeks determined from electronic medical record
  • Age 30-80; determined from electronic medical record
  • Physician clearance to participate in exercise

You may not qualify if:

  • Participation in supervised physical exercise within 6 months prior to study enrollment
  • Currently pregnant or planning to become pregnant
  • Non-English speaking
  • Unable to make own medical decisions and/or to follow verbal instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maple Tree Cancer Alliance

Dayton, Ohio, 45404, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Limitations and Caveats

None to the study itself. Public funding and lack of resources have been identified as a significant barrier to national exercise oncology programs. Other known barriers include lack of general knowledge about the need to stay physically active during and after cancer therapy, qualified personnel, and available programs.

Results Point of Contact

Title
Dr. Karen Wonders
Organization
Maple Tree Cancer Alliance

Study Officials

  • Karen Wonders, PhD, FACSM

    Maple Tree Cancer Alliance

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Executive Director, Maple Tree Cancer Alliance

Study Record Dates

First Submitted

September 25, 2019

First Posted

September 27, 2019

Study Start

August 23, 2019

Primary Completion

October 28, 2021

Study Completion

October 28, 2021

Last Updated

June 7, 2024

Results First Posted

June 7, 2024

Record last verified: 2024-06

Locations